Clinical And Molecular Hepatology

雜志介紹

Clinical And Molecular Hepatology雜志介紹

《Clinical And Molecular Hepatology》是一本以English為主的開放獲取國際優秀期刊，中文名稱臨床和分子肝病學，本刊主要出版、報道醫學-GASTROENTEROLOGY & HEPATOLOGY領域的研究動態以及在該領域取得的各方面的經驗和科研成果，介紹該領域有關本專業的最新進展，探討行業發展的思路和方法，以促進學術信息交流，提高行業發展。該刊已被國際權威數據庫SCIE收錄，為該領域相關學科的發展起到了良好的推動作用，也得到了本專業人員的廣泛認可。該刊最新影響因子為14，最新CiteScore 指數為15.6。

本刊近期中國學者發表的論文主要有：

• Baveno-VII criteria to predict decompensation and initiate non-selective beta-blocker in compensated advanced chronic liver disease patients

  Author: Wong, Yu Jun; Chen, Zhaojin; Tosetti, Guilia; Degasperi, Elisabetta; Sharma, Sanchit; Agarwal, Samagra; Chuan, Liu; Huak, Chan Yiong; Jia, Li; Qi, Xiaolong; Saraya, Anoop; Primignani, Massimo

• Hepatitis B virus pre-genomic RNA and hepatitis B core-related antigen reductions at week 4 predict favourable hepatitis B surface antigen response upon long-term nucleos(t)ide analogue in chronic hepatitis B

  Author: Mak, Lung-Yi; Wong, Danny; Kuchta, Alison; Hilfiker, Martina; Hamilton, Aaron; Chow, Ning; Mao, XianHua; Seto, Wai Kay; Yuen, Man-Fung

• Screening strategy for non-alcoholic fatty liver disease

  Author: Zhang, Saisai; Mak, Lung-Yi; Yuen, Man-Fung; Seto, Wai-Kay

• Non-invasive biomarkers for liver inflammation in non-alcoholic fatty liver disease: present and future

  Author: Yip, Terry Cheuk-Fung; Lyu, Fei; Lin, Huapeng; Li, Guanlin; Yuen, Pong-Chi; Wong, Vincent Wai-Sun; Wong, Grace Lai-Hung

英文介紹

Clinical And Molecular Hepatology雜志英文介紹

Clinical and Molecular Hepatology (Clin Mol Hepatol), is an international, peer-reviewed, open- access journal published quarterly in English. Clin Mol Hepatol aims to share advanced and latest knowledge, trend, and understanding of hepatobiliary diseases, to provide a wide open academic forum for active debate and discussion among clinical doctors, translational researchers, and basic scientists, and to improve public health through a multidisciplinary approach, especially in resource-limited Asia-Pacific area with high prevalence of B viral infection and hepatocellular carcinoma. In addition, Clin Mol Hepatol gives priority to epidemiological studies of hepatobiliary diseases in East Asia, North Asia, Southeast Asia, Central Asia, South Asia, Southwest Asia, Pacific, Africa, Central Europe, Eastern Europe, Central America, and South America.